Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2019 09:00 ET | Source: MannKind

MannKind to Sponsor Andretti Autosport Type 1 Diabetes Driver, Conor Daly

WESTLAKE VILLAGE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) announced today it is sponsoring Conor Daly as he makes his debut with the Andretti Autosport team at...
February 26, 2019 08:00 ET | Source: MannKind

MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call

Conference Call to Begin Today at 9:00 AM ET 4Q 2018 Total Revenues were $16.0 million; 254% growth vs. 4Q 2017 4Q 2018 Afrezza Net Revenue was $5.7 million; 28% growth vs. 4Q 2017 on a GAAP basis...
February 20, 2019 17:00 ET | Source: MannKind

MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)

WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced additional positive Afrezza clinical data to be presented in an oral presentation on...
February 20, 2019 09:00 ET | Source: MannKind

MannKind Corporation Participating at Upcoming Conferences

WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
February 19, 2019 16:31 ET | Source: MannKind

MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019

WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and...
January 16, 2019 16:30 ET | Source: MannKind

MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day

WESTLAKE VILLAGE, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
December 27, 2018 08:00 ET | Source: MannKind

MannKind Corporation to Hold Investor Conference Call

WESTLAKE VILLAGE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will host a conference call on Friday, January 4, 2019 to discuss Company developments at 9:00 AM...
December 19, 2018 23:57 ET | Source: MannKind

MannKind Announces Pricing of $40 Million Public Offering

WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced the pricing of an underwritten public offering of 26,666,667 shares of its...
December 19, 2018 16:01 ET | Source: MannKind

MannKind Announces Commencement of Public Offering

WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue and sell...
November 27, 2018 09:00 ET | Source: MannKind

MannKind Appoints Christine Mundkur to its Board of Directors

WESTLAKE VILLAGE, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that Christine Mundkur has joined its Board of Directors, effective November 27, 2018....